Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia. Read more about Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia.
Cleavage of talin by calpain promotes platelet-mediated fibrin clot contraction. Read more about Cleavage of talin by calpain promotes platelet-mediated fibrin clot contraction.
Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma. Read more about Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma.
CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes. Read more about CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes.
VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis. Read more about VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis.
Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment. Read more about Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment.
5-Azacytidine depletes HSCs and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent mice. Read more about 5-Azacytidine depletes HSCs and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent mice.
American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation. Read more about American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation.
Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia. Read more about Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia.
Macrophage activation syndrome-like manifestations (MAS-L) following BCMA-directed CAR T-cells in multiple myeloma Read more about Macrophage activation syndrome-like manifestations (MAS-L) following BCMA-directed CAR T-cells in multiple myeloma